PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Kaad-Cyclopamine		Drug	Disease	Basal Cell Carcinoma
Kaad-Cyclopamine		Drug	Disease	Breast Cancer
Kaad-Cyclopamine		Drug	Disease	Lung Cancer
Kaad-Cyclopamine		Drug	Disease	Glioblastoma
AMAC-1		Target	Disease	Osteoarthritis
AMAC-1		Target	Disease	Cancer
AMAC-1		Target	Disease	Infection
AMAC-1		Target	Disease	Arthritis
AMAC-1		Target	Disease	Rheumatoid Arthritis
AMAC-1		Target	Disease	Breast Cancer
AMAC-1		Target	Disease	Septic Arthritis
AMAC-1		Target	Disease	Inflammation
Aralen (Chloroquine)- FDA		Drug	Disease	Infectious Diseases
Aralen (Chloroquine)- FDA		Drug	Disease	Infection
Aralen (Chloroquine)- FDA		Drug	Disease	Stroke
Aralen (Chloroquine)- FDA		Drug	Disease	Shock
Aralen (Chloroquine)- FDA		Drug	Disease	Arthritis
Aralen (Chloroquine)- FDA		Drug	Disease	Rheumatoid Arthritis
Aralen (Chloroquine)- FDA		Drug	Disease	Malaria
Aralen (Chloroquine)- FDA		Drug	Disease	Pain
Aralen (Chloroquine)- FDA		Drug	Disease	Breast Cancer
Mu-Type Opioid Receptor		Target	Disease	Pain
464.1		Target	Disease	Hypotension
464.1		Target	Disease	Cholesterol
464.1		Target	Disease	Leukemia
464.1		Target	Disease	Asthma
464.1		Target	Disease	Inflammation
ALK Phos		Target	Disease	Cholesterol
ALK Phos		Target	Disease	Hepatitis
ALK Phos		Target	Disease	Pain
ALK Phos		Target	Disease	Breast Cancer
ALK Phos		Target	Disease	Skin Rash
ALK Phos		Target	Disease	Inflammation
ALK Phos		Target	Disease	Liver Disease
Amitiza (Lubiprostone)- FDA		Drug	Disease	Constipation
Amitiza (Lubiprostone)- FDA		Drug	Disease	Ileus
Amitiza (Lubiprostone)- FDA		Drug	Disease	Irritable Bowel Syndrome
Amitiza (Lubiprostone)- FDA		Drug	Disease	Pain
Eotaxin-2/CCL24		Target	Disease	Rheumatoid Arthritis
Eotaxin-2/CCL24		Target	Disease	Psoriasis
Eotaxin-2/CCL24		Target	Disease	Asthma
Eotaxin-2/CCL24		Target	Disease	Inflammatory Bowel Diseases
Eotaxin-2/CCL24		Target	Disease	Inflammation
Kallikrein-8		Target	Disease	Psoriasis
Kallikrein-8		Target	Disease	Leukemia
Kallikrein-8		Target	Disease	Breast Cancer
Kallikrein-8		Target	Disease	Lung Cancer
Kallikrein-8		Target	Disease	Inflammation
Kallikrein-8		Target	Disease	Glioblastoma
Tegument Protein Vp16		Target	Disease	Pain